Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1918 in Patients With Hyperlipidemia
NCT07230730Phase 3Recruiting
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-1918 in hyperlipidemia, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Jan 2026; status: recruiting.
02
Drugs
SHR-1918
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT07230730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230730.